Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

T 3761

Known as: T-3761 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
To investigate emerging fluoroquinolone resistance in Neisseria gonorrhoeae isolated in Japan, we compared the in vitro… Expand
1995
1995
The effect of a new quinolone, T-3761, on the pharmacokinetics and metabolism of theophylline was investigated with rats. T-3761… Expand
1995
1995
The structures of light degradation products of (-)-(S)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2,3-dih ydr o-7H- pyrido… Expand
1995
1995
The mechanism of the renal excretion of T-3761, a novel oral fluoroquinolone agent, was studied by renal clearance, stop-flow… Expand
1995
1995
We investigated the extent of the binding of T-3761 to serum protein and obtained the following results. 1. The binding rates of… Expand
1995
1995
Phototoxicity and photoallergenicity tests of T-3761 (oral or percutaneous administration) were carried out in guinea pigs… Expand
1994
1994
Some of the many antimicrobial agents (beta-lactams, macrolides, aminoglycosides, tetracyclines, new quinolones; NQs) were… Expand
1993
1993
T-3761, a new quinolone derivative, showed broad and potent antibacterial activity. Its MICs for 90% of the strains tested were 0… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
1993
1993
We evaluated the in vitro antimicrobial activity of NM394 and ofloxacin (OFLX) against representative pathogenic mycobacteria by… Expand
1992
1992
The in vitro activity of T-3761, a new fluoroquinolone antimicrobial agent which has an oxazine ring structure with a cyclopropyl… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2